Nifty

:

11513.90

Sensex

:

39052.06

49.90 (0.44%)
453.07 (1.17%)

Login

Nifty
Sensex

:
:

11513.90
39052.06

49.90 (0.44%)
453.07 (1.17%)

Nectar Lifesciences Ltd.

Pharmaceuticals & Drugs

Rating :

40/99

BSE: 532649 | NSE: NECLIFE

Watchlist

NSE BSE

11.45

17-Oct-2019

Open
High
Low
Previous Close

11.40
11.80
10.90
11.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

160620
18.27
24.30
10.90

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

250.95
5.27
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,133.07
0.45%
0.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.66
11.12
19.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.07
-0.23
3.31

PAT CAGR (%)

10 Years
5 Years
3 Years

-6.43
-6.51
-4.96

P:E (Median)

8 Years
5 Years
3 Years

10.77
12.28
11.50

P:BV (Average)

8 Years
5 Years
3 Years

0.64
0.71
0.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.46
6.07
5.97

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 643.14 594.96 8.10% 798.54 682.91 16.93% 820.22 588.22 39.44% 819.56 480.13 70.70%
Expenses 581.34 534.89 8.68% 724.18 631.69 14.64% 754.54 520.13 45.07% 755.69 415.50 81.87%
EBITDA 61.79 60.08 2.85% 74.37 51.22 45.20% 65.68 68.10 -3.55% 63.87 64.63 -1.18%
EBIDTM 9.61% 10.10% 9.31% 7.50% 8.01% 11.58% 7.79% 13.46%
Other Income 2.13 1.31 62.60% 1.66 1.27 30.71% 1.53 1.68 -8.93% 1.45 1.31 10.69%
Interest 31.47 29.92 5.18% 38.66 30.16 28.18% 36.00 30.70 17.26% 43.55 27.58 57.90%
Depreciation 16.40 16.29 0.68% 14.54 16.16 -10.02% 16.88 16.19 4.26% 15.54 16.50 -5.82%
PBT 16.05 15.17 5.80% 22.83 6.15 271.22% 14.33 22.88 -37.37% 6.22 21.86 -71.55%
Tax 2.55 1.97 29.44% 5.42 2.26 139.82% 3.02 3.88 -22.16% 0.82 2.99 -72.58%
PAT 13.50 13.20 2.27% 17.41 3.89 347.56% 11.32 19.00 -40.42% 5.39 18.87 -71.44%
PATM 2.10% 2.22% 2.18% 0.57% 1.38% 3.23% 0.66% 3.93%
EPS 0.60 0.59 1.69% 0.78 0.17 358.82% 0.50 0.85 -41.18% 0.24 0.84 -71.43%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 638.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 576.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 61.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 9.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 2.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 31.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 16.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 16.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 2.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 2.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 3,081.46 2,784.93 2,067.94 1,643.34 1,676.32 1,643.64 1,638.31 1,626.25 1,313.11 1,062.06 845.80 Net Sales Growth 31.34% 34.67% 25.84% -1.97% 1.99% 0.33% 0.74% 23.85% 23.64% 25.57% Cost Of Goods Sold 2,263.92 2,221.15 1,366.48 1,154.17 1,174.68 1,141.33 1,154.68 1,142.12 906.71 711.07 544.31 Gross Profit 817.54 563.78 701.46 489.17 501.64 502.31 483.63 484.13 406.40 350.99 301.49 GP Margin 26.53% 20.24% 33.92% 29.77% 29.93% 30.56% 29.52% 29.77% 30.95% 33.05% 35.65% Total Expenditure 2,815.75 2,521.03 1,831.90 1,419.13 1,437.49 1,376.73 1,350.44 1,336.17 1,064.56 835.17 650.76 Power & Fuel Cost - 103.47 91.85 75.44 87.89 79.60 66.10 60.94 41.89 33.95 28.92 % Of Sales - 3.72% 4.44% 4.59% 5.24% 4.84% 4.03% 3.75% 3.19% 3.20% 3.42% Employee Cost - 76.54 74.65 75.54 78.38 58.93 47.97 45.64 43.94 33.79 28.91 % Of Sales - 2.75% 3.61% 4.60% 4.68% 3.59% 2.93% 2.81% 3.35% 3.18% 3.42% Manufacturing Exp. - 50.38 52.90 53.32 39.56 37.05 33.57 34.04 29.74 23.92 12.73 % Of Sales - 1.81% 2.56% 3.24% 2.36% 2.25% 2.05% 2.09% 2.26% 2.25% 1.51% General & Admin Exp. - 21.77 23.02 20.05 20.34 21.60 22.03 18.37 17.14 13.02 17.69 % Of Sales - 0.78% 1.11% 1.22% 1.21% 1.31% 1.34% 1.13% 1.31% 1.23% 2.09% Selling & Distn. Exp. - 44.68 221.12 39.00 35.24 35.25 24.71 29.84 18.48 14.84 14.41 % Of Sales - 1.60% 10.69% 2.37% 2.10% 2.14% 1.51% 1.83% 1.41% 1.40% 1.70% Miscellaneous Exp. - 3.04 1.87 1.61 1.41 2.97 1.38 5.22 6.66 4.59 14.41 % Of Sales - 0.11% 0.09% 0.10% 0.08% 0.18% 0.08% 0.32% 0.51% 0.43% 0.45% EBITDA 265.71 263.90 236.04 224.21 238.83 266.91 287.87 290.08 248.55 226.89 195.04 EBITDA Margin 8.62% 9.48% 11.41% 13.64% 14.25% 16.24% 17.57% 17.84% 18.93% 21.36% 23.06% Other Income 6.77 6.04 6.04 22.67 5.78 20.00 12.53 16.04 12.89 13.46 18.95 Interest 149.68 148.13 115.20 117.41 123.31 125.59 137.99 115.49 115.25 74.08 60.28 Depreciation 63.36 63.26 64.31 62.25 57.39 76.56 84.19 75.96 60.73 46.10 38.75 PBT 59.43 58.55 62.57 67.21 63.91 84.75 78.22 114.67 85.47 120.16 114.96 Tax 11.81 11.22 10.41 12.08 9.59 18.49 16.14 29.01 12.22 16.24 22.99 Tax Rate 19.87% 19.16% 16.64% 17.97% 15.01% 21.82% 20.63% 25.30% 14.30% 13.52% 20.00% PAT 47.62 47.33 52.15 55.13 54.33 66.26 62.08 85.67 73.25 103.92 91.97 PAT before Minority Interest 47.62 47.33 52.15 55.13 54.33 66.26 62.08 85.67 73.25 103.92 91.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.55% 1.70% 2.52% 3.35% 3.24% 4.03% 3.79% 5.27% 5.58% 9.78% 10.87% PAT Growth -13.36% -9.24% -5.41% 1.47% -18.00% 6.73% -27.54% 16.96% -29.51% 12.99% Unadjusted EPS 2.12 2.11 2.33 2.46 2.42 2.95 2.77 3.82 3.27 4.63 5.81

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 2,782.86 2,068.66 1,643.70 1,675.69 1,643.64 1,638.31 1,626.25 1,313.11 1,062.06 845.80 Net Sales Growth - 34.52% 25.85% -1.91% 1.95% 0.33% 0.74% 23.85% 23.64% 25.57% Cost Of Goods Sold - 2,217.70 1,367.01 1,154.31 1,174.12 1,141.33 1,154.68 1,142.12 906.71 711.07 544.31 Gross Profit - 565.16 701.65 489.39 501.57 502.31 483.63 484.13 406.40 350.99 301.49 GP Margin - 20.31% 33.92% 29.77% 29.93% 30.56% 29.52% 29.77% 30.95% 33.05% 35.65% Total Expenditure - 2,518.70 1,832.51 1,419.29 1,436.94 1,376.73 1,350.44 1,336.10 1,064.59 834.89 650.85 Power & Fuel Cost - 103.47 91.85 75.44 87.89 79.60 66.10 60.94 41.89 33.95 28.92 % Of Sales - 3.72% 4.44% 4.59% 5.25% 4.84% 4.03% 3.75% 3.19% 3.20% 3.42% Employee Cost - 76.54 74.65 75.54 78.38 58.93 47.97 45.64 43.94 33.79 28.96 % Of Sales - 2.75% 3.61% 4.60% 4.68% 3.59% 2.93% 2.81% 3.35% 3.18% 3.42% Manufacturing Exp. - 50.38 52.90 53.32 39.56 37.05 33.57 34.04 29.74 23.92 12.73 % Of Sales - 1.81% 2.56% 3.24% 2.36% 2.25% 2.05% 2.09% 2.26% 2.25% 1.51% General & Admin Exp. - 21.82 23.02 20.07 20.36 21.60 22.03 18.43 17.17 13.13 17.72 % Of Sales - 0.78% 1.11% 1.22% 1.22% 1.31% 1.34% 1.13% 1.31% 1.24% 2.10% Selling & Distn. Exp. - 45.66 221.12 39.00 35.24 35.25 24.71 29.84 18.48 14.84 14.41 % Of Sales - 1.64% 10.69% 2.37% 2.10% 2.14% 1.51% 1.83% 1.41% 1.40% 1.70% Miscellaneous Exp. - 3.12 1.95 1.61 1.41 2.97 1.38 5.09 6.66 4.19 14.41 % Of Sales - 0.11% 0.09% 0.10% 0.08% 0.18% 0.08% 0.31% 0.51% 0.39% 0.45% EBITDA - 264.16 236.15 224.41 238.75 266.91 287.87 290.15 248.52 227.17 194.95 EBITDA Margin - 9.49% 11.42% 13.65% 14.25% 16.24% 17.57% 17.84% 18.93% 21.39% 23.05% Other Income - 6.04 6.04 22.67 5.78 20.00 12.53 16.04 12.89 13.46 19.40 Interest - 148.14 115.20 117.41 123.31 125.59 137.99 115.49 115.25 74.09 60.30 Depreciation - 63.26 64.31 62.25 57.39 76.56 84.19 75.96 60.73 46.10 38.75 PBT - 58.82 62.68 67.42 63.83 84.75 78.23 114.75 85.43 120.44 115.30 Tax - 11.22 10.41 12.08 9.59 18.49 16.14 29.01 12.22 16.24 23.01 Tax Rate - 19.08% 16.61% 17.92% 15.02% 21.82% 20.63% 25.28% 14.30% 13.48% 19.96% PAT - 47.60 52.27 55.34 54.24 66.26 62.09 85.74 73.22 104.20 92.29 PAT before Minority Interest - 47.60 52.27 55.34 54.24 66.26 62.09 85.74 73.22 104.20 92.29 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 1.71% 2.53% 3.37% 3.24% 4.03% 3.79% 5.27% 5.58% 9.81% 10.91% PAT Growth - -8.93% -5.55% 2.03% -18.14% 6.72% -27.58% 17.10% -29.73% 12.90% Unadjusted EPS - 2.12 2.33 2.47 2.42 2.95 2.77 3.82 3.26 4.65 5.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 1,104.64 1,058.63 1,006.73 954.27 957.95 927.06 867.61 784.55 721.18 620.98 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,082.21 1,036.20 984.30 931.85 935.52 904.64 845.18 762.12 698.76 598.55 Non-Current Liabilities 299.91 355.94 295.66 362.35 396.92 340.94 361.54 432.02 288.67 651.08 Secured Loans 164.40 218.21 161.20 243.44 264.36 222.59 260.48 362.93 233.60 451.01 Unsecured Loans 1.19 1.87 2.60 1.96 1.17 0.75 0.48 0.69 0.74 149.88 Long Term Provisions 9.36 9.07 8.49 6.91 6.01 4.90 3.79 3.43 2.41 0.00 Current Liabilities 1,299.23 1,309.32 1,278.66 1,239.95 1,155.60 1,126.07 1,044.90 904.36 802.77 208.68 Trade Payables 530.78 539.42 528.10 496.78 455.58 440.06 382.52 194.49 139.82 134.52 Other Current Liabilities 122.62 123.40 106.88 107.95 90.50 86.72 131.28 129.84 245.92 9.20 Short Term Borrowings 635.97 634.08 630.34 627.24 595.30 579.84 509.11 565.21 330.01 0.00 Short Term Provisions 9.87 12.41 13.34 7.98 14.22 19.45 22.00 14.81 87.02 64.96 Total Liabilities 2,703.78 2,723.89 2,581.05 2,556.57 2,510.47 2,394.07 2,274.05 2,120.93 1,812.62 1,480.74 Net Block 824.82 852.35 881.24 905.58 933.73 947.54 913.84 857.87 736.26 627.26 Gross Block 1,490.49 1,381.56 1,363.67 1,383.66 1,451.42 1,341.15 1,223.31 1,091.46 909.26 754.17 Accumulated Depreciation 665.68 529.20 482.43 478.08 517.69 393.61 309.47 233.59 173.00 126.91 Non Current Assets 1,036.29 1,063.54 1,085.38 1,092.25 1,105.54 1,156.72 1,122.94 1,071.24 868.60 687.15 Capital Work in Progress 99.55 99.79 102.11 99.35 91.31 122.26 138.57 150.13 82.42 55.51 Non Current Investment 0.60 0.60 0.60 0.60 0.15 0.05 0.05 0.05 0.05 4.38 Long Term Loans & Adv. 108.33 104.19 96.90 82.24 80.34 86.87 70.49 63.19 49.87 0.00 Other Non Current Assets 2.99 6.61 4.53 4.47 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,667.49 1,660.35 1,495.67 1,464.33 1,369.02 1,237.34 1,151.08 1,049.66 944.00 793.55 Current Investments 0.51 0.51 0.41 0.52 0.44 0.31 0.32 0.14 5.33 21.32 Inventories 914.53 859.43 854.13 836.06 790.98 758.43 676.00 591.42 470.88 396.35 Sundry Debtors 561.38 612.12 500.43 492.24 446.50 376.65 349.39 304.49 311.13 222.46 Cash & Bank 20.58 8.91 12.81 36.41 33.38 9.98 6.24 25.92 32.58 30.52 Other Current Assets 170.50 54.82 53.88 31.54 97.73 91.97 119.13 127.69 124.08 122.91 Short Term Loans & Adv. 98.69 124.56 74.01 67.55 84.61 69.02 86.84 105.04 102.03 96.44 Net Current Assets 368.26 351.03 217.01 224.38 213.42 111.27 106.18 145.31 141.22 584.87 Total Assets 2,703.78 2,723.89 2,581.05 2,556.58 2,510.47 2,394.07 2,274.04 2,120.92 1,812.63 1,480.74

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 1,105.16 1,058.66 1,006.68 954.08 957.95 927.06 867.60 784.46 721.13 620.65 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 1,082.73 1,036.23 984.25 931.65 935.52 904.64 845.17 762.04 698.71 598.22 Non-Current Liabilities 299.92 355.84 295.58 362.30 396.92 340.94 361.54 432.02 288.67 651.08 Secured Loans 164.40 218.21 161.20 243.44 264.36 222.59 260.48 362.93 233.60 451.02 Unsecured Loans 1.19 1.87 2.60 1.96 1.17 0.75 0.48 0.69 0.74 149.88 Long Term Provisions 9.36 9.07 8.49 6.91 6.01 4.90 3.79 3.43 2.41 0.00 Current Liabilities 1,299.90 1,309.32 1,278.66 1,239.95 1,155.60 1,126.07 1,044.90 904.38 802.79 208.76 Trade Payables 531.46 539.42 528.10 496.78 455.58 440.06 382.52 194.49 139.83 134.52 Other Current Liabilities 122.62 123.40 106.88 107.95 90.50 86.72 131.28 129.87 245.93 9.28 Short Term Borrowings 635.97 634.08 630.34 627.24 595.30 579.84 509.11 565.21 330.01 0.00 Short Term Provisions 9.87 12.41 13.34 7.98 14.22 19.45 22.00 14.81 87.02 64.96 Total Liabilities 2,704.98 2,723.82 2,580.92 2,556.33 2,510.47 2,394.07 2,274.04 2,120.86 1,812.59 1,480.49 Net Block 824.82 852.35 881.24 905.58 933.73 947.54 913.84 857.87 736.26 627.26 Gross Block 1,490.49 1,381.56 1,363.67 1,383.66 1,451.42 1,341.15 1,223.31 1,091.46 909.26 754.17 Accumulated Depreciation 665.68 529.20 482.43 478.08 517.69 393.61 309.47 233.59 173.00 126.91 Non Current Assets 1,035.96 1,063.21 1,085.05 1,091.92 1,105.54 1,156.72 1,122.94 1,071.18 868.56 682.51 Capital Work in Progress 99.55 99.79 102.11 99.35 91.31 122.26 138.57 150.13 82.42 55.51 Non Current Investment 0.27 0.27 0.27 0.27 0.15 0.05 0.05 0.05 0.05 -0.26 Long Term Loans & Adv. 108.33 104.19 96.90 82.24 80.34 86.87 70.48 63.12 49.84 0.00 Other Non Current Assets 2.99 6.61 4.53 4.47 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,669.03 1,660.61 1,495.86 1,464.42 1,369.02 1,237.34 1,151.08 1,049.67 944.00 797.94 Current Investments 0.51 0.51 0.41 0.52 0.44 0.31 0.32 0.14 5.33 21.32 Inventories 917.97 859.43 854.65 836.71 790.98 758.43 676.00 591.42 470.88 396.35 Sundry Debtors 558.73 611.97 499.73 491.45 446.50 376.65 349.39 304.49 311.13 222.46 Cash & Bank 21.33 9.31 13.18 36.65 33.38 9.98 6.24 25.93 32.58 34.79 Other Current Assets 170.49 54.82 53.88 31.54 97.73 91.97 119.13 127.70 124.08 123.02 Short Term Loans & Adv. 98.69 124.56 74.01 67.55 84.61 69.02 86.84 105.05 102.03 96.55 Net Current Assets 369.13 351.29 217.20 224.47 213.42 111.27 106.18 145.29 141.21 589.18 Total Assets 2,704.99 2,723.82 2,580.91 2,556.34 2,510.47 2,394.07 2,274.04 2,120.87 1,812.59 1,480.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 238.89 65.14 198.62 168.91 144.41 254.87 360.78 164.99 43.97 50.53 PBT 58.55 62.57 67.21 64.83 84.75 78.22 114.67 85.47 120.16 114.96 Adjustment 206.90 175.74 158.85 174.16 185.24 212.94 179.63 156.84 122.49 84.47 Changes in Working Capital -13.00 -160.56 -20.26 -61.52 -119.29 -16.31 68.30 -64.34 -186.01 -136.42 Cash after chg. in Working capital 252.45 77.75 205.80 177.47 150.70 274.85 362.60 177.97 56.64 63.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.56 -12.62 -7.17 -8.56 -6.29 -19.98 -1.83 -12.98 -12.67 -12.48 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.13 -29.43 -18.10 -77.21 -59.53 -89.99 -98.90 -233.59 -164.54 -145.01 Net Fixed Assets -108.69 -15.57 17.23 59.72 -79.32 -101.53 -120.29 -249.91 -182.00 -121.21 Net Investments 0.00 -0.10 0.11 -0.53 -0.23 0.01 -0.18 5.19 20.32 -20.09 Others 82.56 -13.76 -35.44 -136.40 20.02 11.53 21.57 11.13 -2.86 -3.71 Cash from Financing Activity -201.09 -39.60 -204.12 -88.68 -61.47 -161.14 -281.56 61.95 122.63 90.59 Net Cash Inflow / Outflow 11.67 -3.90 -23.60 3.03 23.40 3.74 -19.68 -6.65 2.06 -3.89 Opening Cash & Equivalents 8.91 12.81 36.41 33.38 9.98 6.24 25.93 32.58 30.52 34.40 Closing Cash & Equivalent 20.58 8.91 12.81 36.41 33.38 9.98 6.24 25.93 32.58 30.52

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 239.24 65.17 198.76 168.82 144.41 254.87 360.83 164.96 43.81 55.31 PBT 58.82 62.68 67.42 64.74 84.75 78.22 114.75 85.43 120.44 115.30 Adjustment 207.17 175.82 158.85 174.16 185.24 212.94 179.63 156.84 122.10 84.05 Changes in Working Capital -13.19 -160.72 -20.34 -61.52 -119.29 -16.31 68.28 -64.33 -186.05 -131.53 Cash after chg. in Working capital 252.79 77.79 205.93 177.38 150.70 274.85 362.66 177.94 56.48 67.81 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.56 -12.62 -7.17 -8.56 -6.29 -19.98 -1.83 -12.98 -12.67 -12.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.13 -29.43 -18.10 -76.88 -59.53 -89.99 -98.95 -233.56 -168.65 -145.57 Net Fixed Assets -108.69 -15.57 17.23 59.72 -79.32 -101.53 -120.29 -249.91 -182.00 -121.21 Net Investments 0.00 -0.10 0.11 -0.53 -0.23 0.01 -0.18 5.19 20.32 -20.09 Others 82.56 -13.76 -35.44 -136.07 20.02 11.53 21.52 11.16 -6.97 -4.27 Cash from Financing Activity -201.09 -39.60 -204.12 -88.68 -61.47 -161.14 -281.56 61.95 122.63 90.57 Net Cash Inflow / Outflow 12.02 -3.87 -23.47 3.27 23.40 3.74 -19.68 -6.65 -2.21 0.32 Opening Cash & Equivalents 9.31 13.18 36.65 33.38 9.98 6.24 25.93 32.58 34.79 34.47 Closing Cash & Equivalent 21.33 9.31 13.18 36.65 33.38 9.98 6.24 25.93 32.58 34.79

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 49.26 47.21 44.89 42.55 41.11 41.34 38.69 34.98 32.16 27.69 ROA 1.74% 1.97% 2.15% 2.14% 2.70% 2.66% 3.90% 3.72% 6.31% 6.64% ROE 4.38% 5.05% 5.62% 5.79% 7.17% 6.92% 10.37% 9.73% 15.49% 19.91% ROCE 10.28% 9.12% 9.71% 9.95% 11.58% 12.24% 12.88% 12.00% 14.18% 15.72% Fixed Asset Turnover 2.11 1.52 1.27 1.27 1.25 1.33 1.45 1.35 1.35 1.29 Receivable days 68.75 97.04 103.90 95.54 85.98 77.54 71.26 83.13 86.76 80.29 Inventory Days 103.93 149.46 176.91 165.59 161.85 153.20 138.12 143.44 141.01 153.69 Payable days 72.03 102.40 128.03 119.13 113.39 105.76 76.22 54.56 55.61 86.46 Cash Conversion Cycle 100.66 144.10 152.78 141.99 134.44 124.98 133.15 172.01 172.16 147.52 Total Debt/Equity 0.82 0.90 0.87 1.01 1.00 0.93 1.01 1.33 1.10 0.97 Interest Cover 1.40 1.54 1.57 1.52 1.67 1.57 1.99 1.74 2.62 2.91

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 49.28 47.21 44.89 42.54 41.11 41.34 38.69 34.98 32.15 27.67 ROA 1.75% 1.97% 2.15% 2.14% 2.70% 2.66% 3.90% 3.72% 6.33% 6.67% ROE 4.40% 5.06% 5.64% 5.78% 7.17% 6.92% 10.38% 9.73% 15.53% 19.98% ROCE 10.29% 9.13% 9.73% 9.95% 11.58% 12.24% 12.88% 12.00% 14.21% 15.76% Fixed Asset Turnover 2.11 1.52 1.27 1.26 1.25 1.33 1.45 1.35 1.35 1.29 Receivable days 68.64 96.93 103.72 95.49 85.98 77.54 71.26 83.13 86.76 80.29 Inventory Days 104.21 149.46 176.99 165.71 161.85 153.20 138.12 143.44 141.01 153.69 Payable days 72.05 102.40 128.03 119.13 113.39 105.76 76.22 54.56 55.61 85.15 Cash Conversion Cycle 100.79 143.99 152.69 142.07 134.44 124.98 133.15 172.00 172.16 148.82 Total Debt/Equity 0.82 0.90 0.87 1.01 1.00 0.93 1.01 1.33 1.10 0.97 Interest Cover 1.40 1.54 1.57 1.52 1.67 1.57 1.99 1.74 2.63 2.91

Top Investors:

nsr direct pe mauritius llc

ingain traders, llc

Annual Reports:

News Update:

Fire breaks out at Punjab Unit of Nectar Lifesciences
26th Aug 2019, 11:12 AM

The company is taking the necessary steps to restore the normalcy of production
Read More
Nectar Lifesciences - Quarterly Results
14th Aug 2019, 14:29 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback